APA

Meneghini L. F., Rosenberg K. H., Koenen C., Merilainen M. J. & Lüddeke H. (20070622). Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE study. : Diabetes, obesity & metabolism.

Chicago

Meneghini L F, Rosenberg K H, Koenen C, Merilainen M J and Lüddeke H-J. 20070622. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE study. : Diabetes, obesity & metabolism.

Harvard

Meneghini L. F., Rosenberg K. H., Koenen C., Merilainen M. J. and Lüddeke H. (20070622). Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE study. : Diabetes, obesity & metabolism.

MLA

Meneghini L F, Rosenberg K H, Koenen C, Merilainen M J and Lüddeke H-J. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE study. : Diabetes, obesity & metabolism. 20070622.